Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Therapy Name||SYN004 + SYN125|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|SYN004||EGFR Antibody 29||SYN004 is a monoclonal antibody that binds to and inhibits EGFR signaling, leading to potential anti-tumor activity (NCI Drug Dictionary).|
|SYN125||SYN-125|SYN 125||Limited information is currently available on SYN125 (Apr, 2020).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT04363242||Phase I||SYN125 SYN004 + SYN125||A Study to Find the Maximum Tolerated Dose of SYN125 in People With Advanced Colorectal and Head and Neck Cancer||Recruiting|